A penetration enhancer and its preparation method and application

The preparation of penetration accelerators by combining chitosan and different acids solves the problem of low skin irritation and absorption efficiency in the prior art, and achieves efficient and gentle penetration effects and simplified preparation process, which is suitable for transdermal absorption of drugs.

CN118846092BActive Publication Date: 2024-12-06KUNMING MEDICAL UNIVERSITY
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202411338630.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-09-25
Publication Date
2024-12-06
Estimated Expiration
2044-09-25

AI Technical Summary

Technical Problem

The existing penetration-promoting technology has problems such as skin irritation, complex operation and low transdermal absorption efficiency. The long-term use of traditional penetration agents such as ethanol and propylene glycol can lead to redness, swelling and pain in the skin. Physical methods such as microneedle introduction method have equipment blockage and infection. Risk, traditional pharmacological methods rely on particle size reduction resulting in low absorption efficiency.

Method used

Using chitosan and different acids (such as amygdonic acid, salicylic acid, citric acid, etc.), a permeability promoter with moderate particle size is prepared by reaction of lyophilized and aqueous sodium tripolyphosphate, with positive charge characteristics and microacid molecules. , able to gently peel off the stratum corneum and improve skin moisturizing and cellular affinity.

Benefits of technology

It achieves efficient penetration promotion effect, reduces irritation, improves transdermal absorption efficiency, and simplifies the preparation process. The product particle size is small and uniform, and is suitable for a wide range of drug transdermal absorption applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118846092B_ABST
    Figure CN118846092B_ABST
Patent Text Reader

Abstract

The invention discloses a penetration enhancer and a preparation method and application thereof, belonging to the technical field of medical materials; the penetration enhancer provided by the invention is compounded with different acids by adopting a suitable preparation method, and the surface of the formed penetration enhancer has positive charge characteristics, which can be effectively adsorbed on human skin, increase the contact area with the skin, and the chitosan in the penetration enhancer can improve the moisture retention of the skin and improve the hydration of the epidermis, and when the slightly acidic substance on the surface of the penetration enhancer peels off the stratum corneum, the mildness of the product effect can be improved, thereby achieving a mild penetration-promoting effect as a whole. In addition, the preparation method of the penetration enhancer provided by the invention is simple to operate, which is conducive to actual production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of medical materials, and in particular relates to a penetration enhancer and a preparation method and application thereof. Background Art

[0002] The skin is a natural barrier between our body and the environment, so it has the property of preventing the penetration of compounds and resisting external invasion. Foreign chemicals mainly enter the skin through three pathways: the stratum corneum, the hair follicles, the sebaceous glands, and the sweat duct openings. Since the longitudinal and cross-sectional areas of skin appendages such as hair follicles and sebaceous glands only account for 0.1%-1% of the skin, the transdermal penetration of chemicals mainly occurs through the stratum corneum (about 90% or more). Therefore, the main factors affecting transdermal absorption actually come from the integrity and maturity of the epidermis, the hydration state of the epidermis, the characteristics of the drug itself, the influence of penetration enhancers, etc.; therefore, the various technologies currently developed to promote transdermal absorption are all designed for the stratum corneum, such as: (1) Traditional chemical penetration enhancers will change the arrangement structure and enhance permeability through the interaction of stratum corneum lipids, such as ethanol (alcohol), propylene glycol, and traditional Chinese medicine penetration enhancers (clove, menthol, etc.); (2) Physical penetration enhancement technology uses physical methods to change the structure of the stratum corneum to expand the transdermal pathway, including ion introduction, microneedle technology, and ultrasonic introduction; (3) Traditional pharmaceutical methods use carriers to load chemical substances to change their particle size so that they can effectively penetrate the gaps in the stratum corneum, such as liposomes, alcohol bodies, transfer bodies, microemulsions, solid lipid nanoparticles, etc.; (4) Traditional biological penetration enhancement technology increases the hydration of the skin, increases the content of the keratinocyte interstitial itself, makes the channel moist and fluffy, thereby promoting skin absorption, such as hyaluronic acid and ceramide.

[0003] However, existing penetration enhancement technologies all have certain problems, such as: (1) Long-term use of ethanol, propylene glycol, lauryl alcohol and other traditional penetration enhancers can cause skin redness, swelling, pain and other irritations. (2) Among traditional physical methods, microneedle and ion introduction methods require professional manipulation to avoid a series of problems such as how to ensure that hollow microneedles will not be blocked, how to ensure that microneedles containing active ingredients will not be rubbed off when inserted into the skin, and how to ensure the stability of direct current. On this basis, temporary edema, bleeding and infection caused by some physical methods are also a potential danger. (3) Transdermal materials prepared by previous pharmaceutical methods, such as liposomes, transfersomes, microemulsions, etc., only improve their transdermal absorption efficiency through the single aspect of their small particle size, and the transdermal absorption efficiency is low.

[0004] Therefore, it is necessary to study how to provide a penetration enhancer with good penetration enhancement efficiency. Summary of the invention

[0005] The purpose of the present invention is to overcome the deficiencies of the above-mentioned prior art and provide a penetration enhancer with smaller particle size and higher penetration promoting ability, as well as a preparation method and application thereof.

[0006] To achieve the above object, in a first aspect of the present invention, the present invention provides a method for preparing a penetration enhancer, the preparation method comprising the following steps:

[0007] (1) adding chitosan to a first acid solution, stirring, and then freeze-drying to obtain a first freeze-dried product;

[0008] (2) adding chitosan to the second acid solution, stirring, and then freeze-drying to obtain a second freeze-dried product;

[0009] (3) adding the first freeze-dried product and the second freeze-dried product to an aqueous solution of sodium tripolyphosphate to obtain a mixed reaction solution;

[0010] (4) adding chitosan to the mixed reaction solution in batches to obtain a penetration enhancer;

[0011] The first acid in the first acid solution and the second acid in the second acid solution are independently selected from at least one of mandelic acid, salicylic acid, citric acid, malic acid, lactic acid and acetic acid, and the first acid and the second acid are selected differently.

[0012] The invention provides a penetration enhancer, wherein two different acids are selected, respectively stirred with chitosan and then freeze-dried, then added into a sodium tripolyphosphate aqueous solution, and then chitosan is added in batches. The obtained penetration enhancer has a moderate particle size and has an excellent penetration-promoting effect.

[0013] Specifically, in the first aspect, the positive charge characteristic of the penetration enhancer prepared by the technical solution provided by the present invention can replace the surfactant, and is better adsorbed on the surface of human skin to increase the contact area, thereby enhancing the penetration ability; in the second aspect, the different micro-acid molecules (first acid and second acid) on the surface of the penetration enhancer prepared by the technical solution provided by the present invention can play the effect of gently exfoliating excess stratum corneum, further improve the penetration efficiency, and reduce irritation; in the third aspect, the chitosan used in the penetration enhancer prepared by the technical solution provided by the present invention has good skin moisturizing properties, can better improve the hydration of the epidermis, and further accelerate the penetration-promoting effect of the penetration enhancer; in the fourth aspect, the penetration enhancer prepared by the technical solution provided by the present invention has excellent affinity for human cells, can reduce irritation, and gently promote penetration.

[0014] As a preferred embodiment of the preparation method of the present invention, in step (1), the mass ratio of chitosan to the first acid is (8-12): 0.025.

[0015] Preferably, in step (1), the mass ratio of chitosan to the first acid is 10:0.025.

[0016] The present invention has found that the selection of the mass ratio of chitosan to the first acid in step (1) will affect the particle size and particle size distribution coefficient of the prepared penetration enhancer to a certain extent. When the mass ratio of chitosan to the first acid is (8-12):0.025, the particle size of the obtained product is moderate, below 1000 nm. In particular, when the mass ratio of chitosan to the first acid is further selected to be 10:0.025, the particle size of the obtained product is smaller, thereby achieving a better penetration enhancement effect.

[0017] As a preferred embodiment of the preparation method of the present invention, in step (1), the mass percentage of the first acid in the first acid solution is 0.2-0.6%.

[0018] Preferably, in step (1), the mass percentage of the first acid in the first acid solution is 0.5-0.6%.

[0019] The present invention has been found that the mass percentage of the first acid in the first acid solution in step (1) also affects the particle size of the product. When the mass percentage of the first acid in the first acid solution is selected to be 0.2-0.6%, the particle size of the obtained product is more moderate, below 1000 nm. In particular, when the mass percentage of the first acid in the first acid solution is further selected to be 0.5-0.6%, the particle size of the obtained product is smaller and the penetration-promoting effect is stronger.

[0020] As a preferred embodiment of the preparation method of the present invention, in step (2), the mass ratio of chitosan to the second acid is (8-12): 0.03.

[0021] Preferably, in step (2), the mass ratio of chitosan to the second acid is 10:0.03.

[0022] The present invention has found that in step (2), the mass ratio of chitosan to the second acid also has a significant effect on the performance of the product. When the mass ratio of chitosan to the second acid is (8-12):0.03, the obtained product has better comprehensive performance and smaller particle size. In particular, when the mass ratio of chitosan to the second acid is further selected to be 10:0.03, the obtained product has a better penetration-enhancing effect.

[0023] As a preferred embodiment of the preparation method of the present invention, in step (2), the mass percentage of the second acid in the second acid solution is 0.5-0.8%.

[0024] Preferably, in step (2), the mass percentage of the second acid in the second acid solution is 0.5-0.6%.

[0025] The present invention has found that in step (2), the mass percentage of the second acid in the second acid solution will also affect the comprehensive performance of the product. When the mass percentage of the second acid in the second acid solution is selected to be 0.5-0.8%, the particle size of the obtained product is small, below 1000nm. In particular, when the mass percentage of the second acid in the second acid solution is further selected to be 0.5-0.6%, the particle size of the obtained product is even smaller and the penetration-promoting effect is stronger.

[0026] As a preferred embodiment of the preparation method of the present invention, in step (3), the ratio of the mass of the sodium tripolyphosphate to the sum of the mass of the first acid and the second acid is (2-4): 0.055.

[0027] Preferably, in step (3), the ratio of the mass of the sodium tripolyphosphate to the sum of the mass of the first acid and the second acid is 2:0.055.

[0028] The present invention has found that when the amount of sodium tripolyphosphate added relative to the sum of the masses of the first acid and the second acid is increased to a certain extent, the particle size of the product will be significantly reduced in the early stage. As the amount of sodium tripolyphosphate added is further increased, the particle size will show an increasing trend. When the ratio of the sum of the masses of sodium tripolyphosphate to the first acid and the second acid is selected to be (2-4): 0.055, the particle size of the obtained product is moderate. In particular, when the ratio of the sum of the masses of sodium tripolyphosphate to the first acid and the second acid is further selected to be 2: 0.055, the comprehensive effect of the obtained product is better.

[0029] As a preferred embodiment of the preparation method of the present invention, in step (4), the ratio of the mass of chitosan to the sum of the mass of the first acid and the second acid is (8-12): 0.055.

[0030] Preferably, in step (4), the ratio of chitosan to the sum of the mass of the first acid and the second acid is 10:0.055.

[0031] The present invention has found that the ratio of the sum of the masses of chitosan and the first acid and the second acid will affect the final form of the product. When the ratio of the sum of the masses of chitosan and the first acid and the second acid is further selected to be within the range given by the present invention, the comprehensive effect of the obtained product is better.

[0032] As a preferred embodiment of the preparation method of the present invention, the mass ratio of the first acid to the second acid is (4-6): (5-7).

[0033] Preferably, the mass ratio of the first acid to the second acid is (5-6): (5-6).

[0034] The present invention has found that the mass ratio of the first acid to the second acid also affects the performance of the product. When the mass ratio of the first acid to the second acid is further selected as (4-6):(5-7), the comprehensive performance of the obtained product is better, especially when the mass ratio of the first acid to the second acid is (5-6):(5-6), the comprehensive effect is optimal.

[0035] As a preferred embodiment of the preparation method of the present invention, in step (4), the batches of adding are 6-16 times.

[0036] Preferably, in step (4), the number of batches added is 6-8.

[0037] The present invention has found that adding chitosan in batches can promote the self-assembly of different types of chitosan, so that the reaction can be fully carried out, avoiding the sedimentation of chitosan and causing the product particle size to be too large; when the batches for adding in batches are selected to be 6-16 times, a product with a moderate particle size can be well formed, especially when the batches for adding in batches are further selected to be 6-8 times, the processing is relatively simple and the particle size is small, and the penetration efficiency is higher.

[0038] In a second aspect of the present invention, the present invention provides a penetration enhancer, which is prepared by the preparation method of the present invention.

[0039] In the third aspect of the present invention, the present invention provides a use of a penetration enhancer in promoting transdermal absorption of drugs.

[0040] The penetration enhancer provided by the present invention has an excellent penetration-enhancing effect and can be widely used in the field of promoting transdermal absorption of drugs.

[0041] Compared with the prior art, the present invention has the following beneficial effects:

[0042] The penetration enhancer provided by the present invention is compounded with different acids by adopting a suitable preparation method, and the surface of the formed penetration enhancer has positive charge characteristics, which can be effectively adsorbed on human skin, increase the contact area with the skin, and the chitosan in the penetration enhancer can improve the moisture retention of the skin and improve the hydration of the epidermis. When the slightly acidic substance on the surface of the penetration enhancer peels off the stratum corneum, the mildness of the product effect can be improved, thereby achieving a mild penetration-promoting effect as a whole. In addition, the preparation method of the penetration enhancer provided by the present invention is simple to operate, which is conducive to actual production. BRIEF DESCRIPTION OF THE DRAWINGS

[0043] Figure 1 A schematic diagram of the process of the penetration enhancer provided by the present invention acting on the epidermis;

[0044] Figure 2The graph is a relationship between the total amount of transdermal penetration of the products prepared in Example 1 and Comparative Examples 4-5 and free drugs and the time;

[0045] Figure 3 The curve diagram of the relationship between the total amount of albumin drug permeated through the skin of the products prepared in Example 1 and Comparative Example 6 and the change over time;

[0046] Figure 4 The graph is a relationship between the total amount of collagen drug permeated through the skin and time for the products prepared in Example 1 and Comparative Example 6. DETAILED DESCRIPTION

[0047] In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with specific embodiments.

[0048] Unless otherwise specified, the reagents, methods and equipment used in the present invention are all conventional reagents, methods and equipment in the art; and unless otherwise specified, the raw materials used in parallel experiments are from the same batch of raw materials.

[0049] Chitosan (deacetylation degree ≥ 90%): Shandong Yousuo Chemical Technology Co., Ltd.

[0050] Example 1

[0051] An embodiment of the present invention provides a penetration enhancer, and a preparation method of the penetration enhancer comprises the following steps:

[0052] (1) Weigh 10 mg of chitosan and add it to 5 mL of 0.5% first acid aqueous solution (the first acid is lactic acid), stir and then freeze-dry to obtain a first freeze-dried product;

[0053] (2) Weigh 10 mg of chitosan and add it to 5 mL of 0.6% second acid aqueous solution (the second acid is acetic acid), stir and then freeze-dry to obtain a second freeze-dried product;

[0054] (3) Weigh 2 mg of sodium tripolyphosphate and dissolve it in 5 mL of ultrapure water to obtain a sodium tripolyphosphate aqueous solution;

[0055] (4) adding the first freeze-dried product and the second freeze-dried product into a sodium tripolyphosphate aqueous solution in multiple portions to obtain a mixed reaction solution;

[0056] (5) Weigh 10 mg of chitosan and add it to the mixed reaction solution in 6 portions to obtain a penetration enhancer.

[0057] Example 2

[0058] The embodiment of the present invention provides a penetration enhancer, and the only difference between the penetration enhancer and the embodiment 1 is that the first acid is salicylic acid and the second acid is mandelic acid.

[0059] Example 3

[0060] The embodiment of the present invention provides a penetration enhancer, and the only difference between the penetration enhancer and the embodiment 1 is that the first acid is salicylic acid and the second acid is malic acid.

[0061] Example 4

[0062] The embodiment of the present invention provides a penetration enhancer, and the only difference between the penetration enhancer and the embodiment 1 is that the first acid is salicylic acid and the second acid is lactic acid.

[0063] Example 5

[0064] The embodiment of the present invention provides a penetration enhancer, and the only difference between the penetration enhancer and the embodiment 1 is that the first acid is lactic acid and the second acid is mandelic acid.

[0065] Example 6

[0066] The embodiment of the present invention provides a penetration enhancer, and the only difference between the penetration enhancer and the embodiment 1 is that the first acid is acetic acid and the second acid is salicylic acid.

[0067] Example 7

[0068] The embodiment of the present invention provides a penetration enhancer, and the only difference between the penetration enhancer and the embodiment 1 is that the first acid is acetic acid and the second acid is mandelic acid.

[0069] Example 8

[0070] The embodiment of the present invention provides a penetration enhancer, the only difference between the penetration enhancer and embodiment 1 is that the first acid is a mixture of mandelic acid and lactic acid in a mass ratio of 1:1, and the second acid is salicylic acid.

[0071] Example 9

[0072] The embodiment of the present invention provides a permeation enhancer. The only difference between the permeation enhancer and the embodiment 1 is that in step (1), 10 mg of chitosan is weighed and added to 4.17 mL of 0.6% first acid aqueous solution, stirred and then freeze-dried.

[0073] Example 10

[0074] The embodiment of the present invention provides a permeation enhancer. The only difference between the permeation enhancer and the embodiment 1 is that in step (1), 10 mg of chitosan is weighed and added to 6.25 mL of 0.4% first acid aqueous solution, stirred and then freeze-dried.

[0075] Embodiment 11

[0076] The embodiment of the present invention provides a permeation enhancer. The only difference between the permeation enhancer and the embodiment 1 is that in step (1), 10 mg of chitosan is weighed and added to 12.5 mL of 0.2% first acid aqueous solution, stirred and then freeze-dried.

[0077] Example 12

[0078] The embodiment of the present invention provides a permeation enhancer. The only difference between the permeation enhancer and the embodiment 1 is that in step (2), 10 mg of chitosan is weighed and added to 6 mL of 0.5% second acid aqueous solution (the second acid is acetic acid), stirred and then freeze-dried.

[0079] Embodiment 13

[0080] The embodiment of the present invention provides a permeation enhancer. The only difference between the permeation enhancer and the embodiment 1 is that in step (2), 10 mg of chitosan is weighed and added to 4.29 mL of 0.7% second acid aqueous solution (the second acid is acetic acid), stirred and then freeze-dried.

[0081] Embodiment 14

[0082] The embodiment of the present invention provides a permeation enhancer. The only difference between the permeation enhancer and the embodiment 1 is that in step (2), 10 mg of chitosan is weighed and added to 3.75 mL of 0.8% second acid aqueous solution (the second acid is acetic acid), stirred and then freeze-dried.

[0083] Embodiment 15

[0084] The embodiment of the present invention provides a penetration enhancer. The only difference between the penetration enhancer and the embodiment 1 is step (1) and step (2). Step (1) and step (2) of the embodiment are:

[0085] (1) Weigh 12 mg of chitosan and add it to 5 mL of 0.6% first acid aqueous solution (the first acid is lactic acid), stir and then freeze-dry to obtain a first freeze-dried product;

[0086] (2) Weigh 8.3 mg of chitosan and add it to 5 mL of 0.5% aqueous solution of a second acid (the second acid is acetic acid), stir, and then freeze-dry to obtain a second freeze-dried product.

[0087] Example 16

[0088] The embodiment of the present invention provides a penetration enhancer. The only difference between the penetration enhancer and the embodiment 1 is step (1) and step (2). Step (1) and step (2) of the embodiment are:

[0089] (1) Weigh 8.0 mg of chitosan and add it to 5 mL of 0.4% first acid aqueous solution (the first acid is lactic acid), stir and then freeze-dry to obtain a first freeze-dried product;

[0090] (2) Weigh 11.7 mg of chitosan and add it to 5 mL of 0.7% aqueous solution of a second acid (the second acid is acetic acid), stir, and then freeze-dry to obtain a second freeze-dried product.

[0091] Embodiment 17

[0092] The embodiment of the present invention provides a penetration enhancer. The only difference between the penetration enhancer and the embodiment 1 is step (1) and step (2). Step (1) and step (2) of the embodiment are:

[0093] (1) Weigh 6.0 mg of chitosan and add it to 5 mL of 0.3% first acid aqueous solution (the first acid is lactic acid), stir and then freeze-dry to obtain a first freeze-dried product;

[0094] (2) Weigh 13.3 mg of chitosan and add it to 5 mL of 0.8% aqueous solution of a second acid (the second acid is acetic acid), stir, and then freeze-dry to obtain a second freeze-dried product.

[0095] Embodiment 18

[0096] The embodiment of the present invention provides a penetration enhancer. The only difference between the penetration enhancer and the embodiment 1 is step (1) and step (2). Step (1) and step (2) of the embodiment are:

[0097] (1) Weigh 16.0 mg of chitosan and add it to 5 mL of 0.8% first acid aqueous solution (the first acid is lactic acid), stir and then freeze-dry to obtain a first freeze-dried product;

[0098] (2) Weigh 5 mg of chitosan, add it to 5 mL of 0.3% second acid aqueous solution (the second acid is acetic acid), stir, and then freeze-dry to obtain a second freeze-dried product.

[0099] Embodiment 19

[0100] The embodiment of the present invention provides a permeation enhancer. The only difference between the permeation enhancer and the embodiment 1 is that in step (1), 5 mg of chitosan is weighed and added to 5 mL of 0.5% first acid aqueous solution (the first acid is lactic acid), stirred, and then freeze-dried.

[0101] Embodiment 20

[0102] The embodiment of the present invention provides a permeation enhancer. The only difference between the permeation enhancer and the embodiment 1 is that in step (1), 8 mg of chitosan is weighed and added to 5 mL of 0.5% first acid aqueous solution (the first acid is lactic acid), stirred, and then freeze-dried.

[0103] Embodiment 21

[0104] The embodiment of the present invention provides a permeation enhancer, the only difference between the permeation enhancer and the embodiment 1 is that in step (1), 12 mg of chitosan is weighed and added to 5 mL of 0.5% first acid aqueous solution (the first acid is lactic acid), stirred and then freeze-dried.

[0105] Embodiment 22

[0106] The embodiment of the present invention provides a permeation enhancer. The only difference between the permeation enhancer and the embodiment 1 is that in step (1), 15 mg of chitosan is weighed and added to 5 mL of 0.5% first acid aqueous solution (the first acid is lactic acid), stirred, and then freeze-dried.

[0107] Embodiment 23

[0108] The embodiment of the present invention provides a penetration enhancer, and the only difference between the penetration enhancer and the embodiment 1 is that in step (3), 1 mg of sodium tripolyphosphate is weighed and dissolved in 5 mL of ultrapure water.

[0109] Embodiment 24

[0110] The embodiment of the present invention provides a penetration enhancer, and the only difference between the penetration enhancer and the embodiment 1 is that in step (3), 3 mg of sodium tripolyphosphate is weighed and dissolved in 5 mL of ultrapure water.

[0111] Embodiment 25

[0112] The embodiment of the present invention provides a penetration enhancer, and the only difference between the penetration enhancer and the embodiment 1 is that in step (3), 4 mg of sodium tripolyphosphate is weighed and dissolved in 5 mL of ultrapure water.

[0113] Embodiment 26

[0114] The embodiment of the present invention provides a penetration enhancer. The only difference between the penetration enhancer and the embodiment 1 is that in step (3), 10 mg of chitosan is weighed and added to the mixed reaction solution in two times.

[0115] Embodiment 27

[0116] The embodiment of the present invention provides a penetration enhancer. The only difference between the penetration enhancer and the embodiment 1 is that in step (3), 10 mg of chitosan is weighed and added to the mixed reaction solution in 4 times.

[0117] Embodiment 28

[0118] The embodiment of the present invention provides a penetration enhancer. The only difference between the penetration enhancer and the embodiment 1 is that in step (3), 10 mg of chitosan is weighed and added to the mixed reaction solution in 8 times.

[0119] Embodiment 29

[0120] The embodiment of the present invention provides a penetration enhancer. The only difference between the penetration enhancer and the embodiment 1 is that in step (3), 10 mg of chitosan is weighed and added to the mixed reaction solution in 16 times.

[0121] Comparative Example 1

[0122] The comparative example of the present invention provides a penetration enhancer, the only difference between the penetration enhancer and Example 1 is that the first acid is retinoic acid and the second acid is acetic acid.

[0123] Comparative Example 2

[0124] The comparative example of the present invention provides a penetration enhancer, the only difference between the penetration enhancer and Example 1 is that the first acid is retinoic acid and the second acid is mandelic acid.

[0125] Comparative Example 3

[0126] The comparative example of the present invention provides a penetration enhancer, the only difference between the penetration enhancer and Example 1 is that in step (5), 10 mg of chitosan is weighed and added to the mixed reaction solution at one time.

[0127] Comparative Example 4

[0128] The comparative example of the present invention provides a penetration enhancer, and the preparation method of the penetration enhancer comprises the following steps:

[0129] (1) Weigh 10 mg of chitosan and add it to 5 mL of 0.5% first acid aqueous solution (the first acid is lactic acid), stir and then freeze-dry to obtain a first freeze-dried product;

[0130] (2) Weigh 2 mg of sodium tripolyphosphate and dissolve it in 5 mL of ultrapure water to obtain a sodium tripolyphosphate aqueous solution;

[0131] (3) adding the first freeze-dried product into a sodium tripolyphosphate aqueous solution in multiple portions to obtain a mixed reaction solution;

[0132] (4) Weigh 10 mg of chitosan and add it to the mixed reaction solution in 6 portions to obtain a penetration enhancer.

[0133] Comparative Example 5

[0134] The comparative example of the present invention provides a penetration enhancer, and the preparation method of the penetration enhancer comprises the following steps:

[0135] (1) Weigh 10 mg of chitosan and add it to 5 mL of 0.6% second acid aqueous solution (the second acid is acetic acid), stir and then freeze-dry to obtain a second freeze-dried product;

[0136] (2) Weigh 2 mg of sodium tripolyphosphate and dissolve it in 5 mL of ultrapure water to obtain a sodium tripolyphosphate aqueous solution;

[0137] (3) adding the second freeze-dried product into the sodium tripolyphosphate aqueous solution in multiple portions to obtain a mixed reaction solution;

[0138] (4) Weigh 10 mg of chitosan and add it to the mixed reaction solution in 6 portions to obtain a penetration enhancer.

[0139] Comparative Example 6

[0140] The comparative example of the present invention provides a penetration enhancer, and the preparation method of the penetration enhancer comprises the following steps:

[0141] (1) Weigh 10 mg of chitosan and dissolve it in 10 mL of 1% acetic acid solution at room temperature, then adjust the pH value to 5.0 and filter it with a 0.45 μm filter membrane;

[0142] (2) STPP was dissolved in ultrapure water to form a solution with a mass concentration of 2 mg / mL, filtered with a 0.45 μm filter membrane, and a certain volume of STPP solution was measured under continuous magnetic stirring (the final CS / STPP mass ratio was 6:1);

[0143] (3) The fixed volume of STPP solution obtained in step (2) is quickly added to the solution obtained in step (1) preheated to a specific temperature (50°C), and stirring is maintained for 10 minutes to obtain a penetration enhancer.

[0144] Effect Example 1

[0145] Effect Examples of the Invention The particle size, particle size distribution coefficient (PDI) and Zeta potential of the products prepared in Examples 1-29 and Comparative Examples 1-6 were tested. The particle size and particle size distribution coefficient were tested using a laser particle size analyzer (Brookheaven), and the Zeta potential was tested using a Zeta potential meter. The test results are shown in Table 1;

[0146] Table 1

[0147]

[0148] It can be seen from Table 1 that when the technical solution provided by the present invention is used for preparation, the obtained product has a moderate particle size, a uniform particle size distribution, and a positive Zeta potential; specifically, the particle size of the obtained product is below 2191.88 nm, and the PDI is below 0.514.

[0149] Effect Example 2

[0150] The effect example of the present invention tests the penetration-promoting effect of the products with a particle size of less than 1000 nm prepared in the example and the products prepared in comparative examples 1-2 and comparative examples 4-6. The test uses a drug transdermal diffusion instrument TPY-2 to conduct an in vitro transdermal experiment. Different products are used to encapsulate drugs with the same protein concentration to obtain test samples. 24h continuous sampling and detection are performed to explore the transdermal efficiency by calculating the total amount of transdermal drugs. Specifically, the following steps are included:

[0151] 1. Preparation of test samples

[0152] Example 1 The sample preparation is as follows:

[0153] 1) Weigh 10 mg of chitosan and add it to 5 mL of 0.5% first acid aqueous solution (the first acid is lactic acid), stir and then freeze-dry to obtain a first freeze-dried product;

[0154] 2) Weigh 10 mg of chitosan and add it to 5 mL of 0.6% second acid aqueous solution (the second acid is acetic acid), stir and freeze-dry to obtain a second freeze-dried product;

[0155] 3) Weigh 2 mg of sodium tripolyphosphate and 13 mg of albumin and dissolve them in 5 mL of ultrapure water to obtain an aqueous solution of sodium tripolyphosphate and albumin;

[0156] 4) adding the first freeze-dried product and the second freeze-dried product to the aqueous solution of sodium tripolyphosphate and albumin in multiple times to obtain a mixed reaction solution;

[0157] 5) Weigh 10 mg of chitosan and add it to the mixed reaction solution in 6 portions to obtain the test sample of Example 1;

[0158] The remaining test samples were prepared in the same manner as in the corresponding examples and comparative examples, except that sodium tripolyphosphate and 13 mg of albumin were weighed simultaneously in step (3).

[0159] 2. Testing process

[0160] (1) Preparation and processing of ex vivo skin of SD rats: Take healthy SD rats, depilate the abdomen, remove the full-thickness skin of the abdomen, rinse it with saline, then wet it with saline and carefully wipe it with cotton cloth to remove subcutaneous tissue (loose connective tissue and adipose tissue), and remove muscles, etc. (be careful not to damage the dermis when wiping). After rinsing the skin with saline several times, soak the skin in saline for use;

[0161] (2) Experimental process: First, use ultrapure water to clean the equipment required for the experiment; add an appropriate amount of water to the drug transdermal diffusion tester TPY-2, adjust the temperature to 32℃, and the speed to 200 r / min; place the stirrer in the receiving pool of the vertical diffusion cell, fill it with physiological saline (so that the surface of the physiological saline can fully contact the skin), and evenly spread the treated SD rat epidermis on the bottle mouth of the receiving pool of the vertical diffusion cell, and no gaps should be left (the epidermis contacts the drug administration pool). Align the drug administration pool of the vertical diffusion cell with the bottle mouth of the receiving pool, use a clamp to fix the drug administration pool and the receiving pool of the vertical diffusion cell, and configure 3N vertical diffusion cells for transdermal experiments, and label them respectively; place the receiving pool of the vertical diffusion cell in the drug transdermal diffusion tester TPY-2, add 2 mL of the test sample to the drug administration pool of each vertical diffusion cell, quickly close the drug transdermal diffusion tester TPY-2, start the transdermal experiment, and start timing. The receiving solution was sampled for 24 hours continuously for testing (100 uL was sampled each time and 100 uL of normal saline was supplemented at the same time), and the total amount of drug transdermally transdermally in 24 hours was obtained and recorded.

[0162] 3. Calculation process

[0163] The total amount of drug permeated through the skin Q is calculated as follows: Q = [Cn × V + ΣCi × V0] / S (i = 1, 2, 3 ...) Q: total amount of drug permeated through the skin; S: effective diffusion area (1.8 cm 2 ); V: volume of receiving solution in the receiving chamber (7 mL); V0: volume of each sampling (0.1 mL); Ci: drug concentration in the receiving solution from the first sampling to the last sampling (mg / mL); Cn: drug concentration in the receiving solution at the nh sampling.

[0164] The test results are shown in Table 2;

[0165] Table 2

[0166]

[0167] It can be seen from Table 2 that when the technical solution of the present invention is adopted, the obtained product has a strong permeation promoting effect, and the total amount of transdermal drugs in 24 hours is more than 4.78 mg; it can be seen from Example 1 and Comparative Examples 1-2 that when the types of the first acid and the second acid selected are not within the range given by the present invention, the permeation promoting effect of the obtained product is significantly reduced, and compared with Example 1, the total amount of transdermal drugs in 24 hours is reduced by 50.27-60.33%; it can be seen from Example 1 and Comparative Examples 4-5 that when only any one of the acids is added, the permeation promoting effect of the obtained product is also significantly reduced, and compared with Example 1, the total amount of transdermal drugs in 24 hours is reduced by 24.26-52.79%.

[0168] The effect of the product prepared in Example 1 on the epidermis is shown in the schematic diagram Figure 1 As shown, from Figure 1 It can be seen that the product provided by the present invention can promote penetration layer by layer when acting on the epidermis, and achieve the effect of peeling layer by layer and promoting penetration;

[0169] In addition, the relationship curve of the total amount of transdermal drug of Example 1, Comparative Example 4, Comparative Example 5 and free drug over time is as follows: Figure 2 As shown, from Figure 2 It can be seen that, as time increases, the amount of drug released using the method of the present invention is significantly higher than that of free drug or single acid-mediated release.

[0170] In addition, the penetration enhancing effects of the products prepared in Example 1 (layered penetration enhancing modification) and Comparative Example 6 (traditional preparation) on different drugs were investigated, wherein drug 1 was albumin (corresponding to Figure 3 ), drug 2 is collagen (corresponding to Figure 4 ), the loading process is consistent with the loading process in Example 2, and the corresponding curves of the change of the total amount of transdermal drug over time are as follows: Figure 3-4 As shown, from Figure 3-4 It can be seen that the penetration-promoting effect of the product obtained by the technical solution of the present invention is significantly enhanced, which is obviously better than the penetration-promoting effect of the product prepared by the traditional preparation method (Comparative Example 6).

[0171] Effect Example 3

[0172] The irritation of the product with a particle size of less than 1000 nm prepared in the test example was tested. The test used a recognized skin irritation reaction scoring table and was tested by applying the medicine on the back of rats for one week. (After depilating the same area on the back of SD rats, an equal amount of sample was applied regularly every day, and the skin irritation reaction scoring standard was used to score on the first day of administration and one week after administration), wherein the irritation reaction scoring standard is shown in Table 3, and the skin irritation intensity evaluation standard is shown in Table 4;

[0173] Table 3

[0174]

[0175] Table 4

[0176]

[0177] The results obtained are shown in Table 5;

[0178] Table 5

[0179]

[0180] It can be seen from Table 5 that the product prepared by the technical solution of the present invention is non-irritating.

[0181] Finally, it should be noted that the above embodiments are intended to illustrate the technical solution of the present invention rather than to limit the scope of protection of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention may be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.

Claims

1. A method for preparing a penetration enhancer, characterized in that: The preparation method comprises the following steps: (1) adding chitosan to a first acid solution, stirring, and then freeze-drying to obtain a first freeze-dried product; (2) adding chitosan to the second acid solution, stirring, and then freeze-drying to obtain a second freeze-dried product; (3) adding the first freeze-dried product and the second freeze-dried product to an aqueous solution of sodium tripolyphosphate to obtain a mixed reaction solution; (4) adding chitosan to the mixed reaction solution in batches to obtain a penetration enhancer; The first acid in the first acid solution and the second acid in the second acid solution are each independently selected from at least one of mandelic acid, salicylic acid, malic acid, lactic acid, and acetic acid, and the first acid and the second acid are selected differently; In step (4), the batches added in batches are 6-16 times.

2. The preparation method according to claim 1, characterized in that: In step (1), the mass percentage of the first acid in the first acid solution is 0.2-0.6%.

3. The preparation method according to claim 1, characterized in that: In step (2), the mass percentage of the second acid in the second acid solution is 0.5-0.8%.

4. The preparation method according to claim 1, characterized in that: The mass ratio of the first acid to the second acid is (4-6):(5-7).

5. A penetration enhancer, characterized in that The penetration enhancer is prepared by the preparation method according to any one of claims 1 to 4.

6. Use of the penetration enhancer as claimed in claim 5 in the preparation of a preparation for promoting transdermal absorption of drugs.

Citation Information

Patent Citations

  • Application of N-arginine chitosan as percutaneous sorbefacient

    CN101780281A

  • 3,5-dyhydroxyl-4-isopropyl diphenylethene chitosan gel and preparation method thereof

    CN102657602A

  • Insulin nano transdermal patch and preparation method thereof

    CN103705494A

  • Chitosan spraying film agent and preparation method thereof

    CN104856978A

  • Chitosan-finasteride nanocrystal microneedle preparation for enhancing skin retention and preparation method of chitosan-finasteride nanocrystal microneedle preparation

    CN117883361A